Affiliation:
1. From the Department of Urology; Department of Public Health; Department of Pathology, Rennes University Hospital, Rennes; Department of Urology, Centre Hospitalier Universitaire (CHU) Henri Mondor, Creteil; Department of Urology, North Hospital, CHU of Saint-Etienne, France; University of California, Los Angeles (UCLA) Department of Urology; Department of Biostatistics, UCLA School of Medicine, Los Angeles, CA; Department of Urology, Medical School of University Federico II, Naples; Department of Urology...
Abstract
PurposeTo analyze to what extent histologic subtype is of prognostic importance in renal cell carcinoma based on a large, international, multicenter experience.Patients and MethodsFour thousand sixty-three patients from eight international centers were included in this retrospective study. Histologic subtype (1997 International Union Against Cancer [UICC] criteria of tumor response), age, sex, TNM stage, Fuhrman grade, tumor size, Eastern Cooperative Oncology Goup performance status (ECOG PS), and overall survival were determined in all cases. The prognostic values of clear cell, papillary, and chromophobe histologic features were assessed by uni- and multivariate analysis using the Kaplan-Meier method and Cox model, respectively.ResultsClear cell, papillary, and chromophobe carcinomas accounted for 3,564 (87.7%), 396 (9.7%) and 103 (2.5%) cases, respectively. In univariate analysis, a trend toward a better survival was observed when clear cell, papillary, and chromophobe histologies were considered prognostic categories (log-rank P = .0007). However, in multivariate analysis, TNM stage, Fuhrman grade and ECOG PS, but not histology, were retained as independent prognostic variables (P < .001).ConclusionThe stratification in three main renal cell carcinoma histologic subtypes as defined by the 1997 UICC–American Joint Committee on Cancer consensus should not be considered a major prognostic variable comparable to TNM stage, Fuhrman grade and ECOG PS.
Publisher
American Society of Clinical Oncology (ASCO)
Cited by
631 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献